Literature DB >> 18308962

Exacerbations in cystic fibrosis: 4--Non-cystic fibrosis bronchiectasis.

A B Chang1, D Bilton.   

Abstract

Bronchiectasis unrelated to cystic fibrosis (CF) is increasingly recognised as an important and major primary respiratory disease in developing countries. In affluent countries, bronchiectasis is also increasingly recognised in subsections of communities (such as indigenous peoples) as well as a co-existent disease/co-morbidity and disease modifier in respiratory diseases such as chronic obstructive pulmonary disease. The epidemiology, pathogenesis, prevention and management of exacerbations of non-CF bronchiectasis are reviewed. There are few data on all aspects of exacerbations in bronchiectasis. Some of the management issues are common to non-CF and CF bronchiectasis, but it would be unwise to extrapolate from CF studies to non-CF bronchiectasis. In some situations this may be harmful.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308962     DOI: 10.1136/thx.2006.060913

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  28 in total

Review 1.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

2.  Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases.

Authors:  Guillaume Geri; Sabrina Dadoun; Tach Bui; Nuria Del Castillo Pinol; Simon Paternotte; Maxime Dougados; Laure Gossec
Journal:  BMC Infect Dis       Date:  2011-11-02       Impact factor: 3.090

3.  Evaluation of Noncystic Fibrosis Bronchiectasis Using Clinical and Radiological Scorings in Children.

Authors:  Abdurrahman Erdem Başaran; Ayşen Başaran; İbrahim Cemal Maslak; Gökhan Arslan; Ayşen Bingöl
Journal:  Turk Thorac J       Date:  2018-09-13

Review 4.  Singing for children and adults with bronchiectasis.

Authors:  Jung Yoon Irons; Dianna Theadora Kenny; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

5.  The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial.

Authors:  Annemarie L Lee; Nola Cecins; Catherine J Hill; Anne E Holland; Linda Rautela; Robert G Stirling; Phillip J Thompson; Christine F McDonald; Sue Jenkins
Journal:  BMC Pulm Med       Date:  2010-02-02       Impact factor: 3.317

Review 6.  Airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2015-11-23

7.  Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.

Authors:  Anne B Chang; Keith Grimwood; Colin F Robertson; Andrew C Wilson; Peter P van Asperen; Kerry-Ann F O'Grady; Theo P Sloots; Paul J Torzillo; Emily J Bailey; Gabrielle B McCallum; Ian B Masters; Catherine A Byrnes; Mark D Chatfield; Helen M Buntain; Ian M Mackay; Peter S Morris
Journal:  Trials       Date:  2012-08-31       Impact factor: 2.279

8.  Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.

Authors:  Patricia C Valery; Peter S Morris; Keith Grimwood; Paul J Torzillo; Catherine A Byrnes; I Brent Masters; Paul A Bauert; Gabrielle B McCallum; Charmaine Mobberly; Anne B Chang
Journal:  BMC Pediatr       Date:  2012-08-14       Impact factor: 2.125

Review 9.  Clinical application of exhaled nitric oxide measurement in pediatric lung diseases.

Authors:  Angelo Manna; Carlo Caffarelli; Margherita Varini; Carlotta Povesi Dascola; Silvia Montella; Marco Maglione; Francesco Sperlì; Francesca Santamaria
Journal:  Ital J Pediatr       Date:  2012-12-31       Impact factor: 2.638

10.  Chest pain and exacerbations of bronchiectasis.

Authors:  Paul T King; Stephen R Holdsworth; Michael Farmer; Nicholas J Freezer; Peter W Holmes
Journal:  Int J Gen Med       Date:  2012-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.